Bortezomib Injections

Price 48.60-50 USD ($)/ Unit

Get a Price/Quote

MOQ : 1000 Units

Bortezomib Injections Specification

Drug Type
Injection

Ingredients
Bortezomib 2mg, 3.5mg

Physical Form
Powder

Function
Anti-Cancer

Dosage
As Directed By Physician

Dosage Guidelines
As Directed By Physician

Storage Instructions
Store In A Cool & Dry Place

Bortezomib Injections Trade Information

Minimum Order Quantity
1000 Units

FOB Port
ALL INDIA

Payment Terms
Western Union, Paypal, Telegraphic Transfer (T/T), Cash in Advance (CID), Cash Advance (CA)

Supply Ability
1000 Units Per Month

Delivery Time
2-3 Week

Sample Policy
Sample costs shipping and taxes has to be paid by the buyer

Packaging Details
Sterile Single Dose vial (Lyophilized)

Main Export Market(s)
Western Europe, Australia, North America, South America, Eastern Europe, Middle East, Central America, Asia, Africa

Main Domestic Market
All India

Certifications
WHO,GMP,COA As Per Client Requirement

About Bortezomib Injections

What Is Bortezomib?
Bortezomib contains the active substance bortezomib, the so-called proteasome inhibitor which plays important role in controlling the growth and function of the cell.

Bortezomib Injection Uses
This medication is used for the treatment of

Multiple Myeloma
Mantle Cell Lymphoma

How Does Bortezomib Injection Works?
It works by helping the breakdown down proteins that the cell doesn't need and blocks the proteasomes so the protein builds up inside the cell which causes cell death.

Available Strength:

Bortezomib 2Mg
Bortezomib 3.5Mg

Tags:
Bortezomib injection wholesaler, Bortezomib injection wholesaler in India, Bortezomib injection seller, Bortezomib injection

Additional Information

The most widely recognized markets for this item incorporate the accompanying nations.you don't mind ask with us if your nation or district isn't recorded:

ASIA:A Afghanistan, Israel, Jordan, Pakistan, Russia, Saudi Arabia, Singapore, Syria, Philippines, Turkey, Turkmenistan, Uzbekistan, Yemen, Vietnam, Indonesia, Malaysia, Iran, Tajikistan, and so forth.

AFRICA:A South Africa, Uganda, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast , and so forth.

NORTH & SOUTH AMERICA:A USA, Canada, Panama, Trinidad and Tobago, Costa Rica, Puerto Rico, Dominican Republic, Argentina, Guatemala, Guyana, Peru, Bolivia, Venezuela , Brazil, Bahamas, Ecuador, and so forth .

EUROPE:A Austria , Azerbaijan, Belarus, Belgium, Cyprus, Czech Republic, Denmark, France, Georgia, Germany, Hungary, Ireland, Iceland, Netherlands, Norway, Poland, Spain, Sweden, Switzerland, Ukraine, United Kingdom (UK) , Latvia, and so forth.

OCEANIA:A Australia, New Zealand, Fiji, and so forth.

Targeted Cancer Therapy

Bortezomib Injections are recognized for their efficacy in treating multiple myeloma and specific types of lymphoma. By inhibiting proteasome activity in cancer cells, Bortezomib helps to interrupt tumor growth and reduce cancer cell proliferation. These targeted therapies are crucial in the management of advanced malignancies and improve overall treatment outcomes for patients.

Powder Form for Enhanced Stability

Available as a powder for injection, Bortezomib maintains greater stability and potency until it is reconstituted right before use. This format helps preserve the medication's effectiveness during storage and transportation. Healthcare professionals must handle its preparation and administration with care, ensuring optimal dosage and safety for the patient.

Convenient and Safe Storage

Bortezomib Injections should always be stored in a cool and dry environment, away from direct light and moisture. Proper storage ensures the medication retains its intended potency and does not degrade prematurely. Adhering to recommended storage guidelines is essential in maintaining product quality for both healthcare facilities and end-users.

FAQ's of Bortezomib Injections:

Q: How should Bortezomib Injections be administered?

A: Bortezomib Injections must be prepared and administered by trained healthcare professionals, typically as an intravenous or subcutaneous injection. The dosing schedule and method are determined by your physician based on your specific medical condition.

Q: What is the physical form and main ingredient of Bortezomib Injections?

A: This medication is supplied in powder form and contains Bortezomib as the active ingredient, available in doses of 2mg or 3.5mg per vial.

Q: When should I take Bortezomib Injections and at what dose?

A: Bortezomib Injections are administered according to your physician's instructions. The dosage and frequency are individualized, depending on your type of cancer, treatment response, and overall health.

Q: Where should Bortezomib Injections be stored before use?

A: Store Bortezomib vials in a cool and dry place, away from direct sunlight and moisture, to maintain the drug's stability and potency.

Q: What is the process for preparing Bortezomib Injections for use?

A: Healthcare professionals will reconstitute the powder with a sterile solution immediately before administration. Proper mixing and handling protocols are essential to ensure safe delivery of the medication.

Q: What are the main benefits of Bortezomib Injections in cancer treatment?

A: Bortezomib Injections work by disrupting cancer cell growth, offering effective control over multiple myeloma and some lymphomas. This targeted approach can improve patient outcomes and prolong remission periods when used as part of a comprehensive treatment regimen.

Tell us about your requirement